Public Health Impact of Potential Infant MenACWY Vaccination Strategies in Spain
<b>Background:</b> The Spanish Interterritorial Council of the National Health System (a central government body) currently recommends vaccination against meningococcal serogroup C (MenC) at 4 and 12 months of age for prevention of invasive meningococcal disease (IMD). The Advisory Commi...
Saved in:
| Main Authors: | Katharina Schley, Jamie Findlow, Carlos Molina, Shannon M. Sullivan, Eszter Tichy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/6/642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public health impact and cost-effectiveness of introducing MenACWY vaccination strategies in Germany
by: Katharina Schley, et al.
Published: (2025-05-01) -
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01) -
Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
by: Sebastian Gruhn, et al.
Published: (2025-03-01) -
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)
by: Ener Cagri Dinleyici, et al.
Published: (2025-12-01) -
Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease
by: Shravani Bobde, et al.
Published: (2025-12-01)